FAF
EXAS

Fjarde Ap-fonden’s Exact Sciences EXAS Stock Holding History

Fjarde Ap-fonden’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-38,488
Closed -$1.67M – 508
2025
Q1 		$1.67M Sell
38,488
-8,000
-17% -$405K 0.02% 470
2024
Q4 		$2.61M Sell
46,488
-4,200
-8% -$261K 0.03% 445
2024
Q3 		$3.45M Buy
+50,688
New +$2.86M 0.04% 416
2024
Q1 		$3.92M Buy
56,788
+2,100
+4% +$133K 0.04% 406
2023
Q4 		$4.05M Buy
54,688
+4,600
+9% +$302K 0.05% 376
2023
Q3 		$3.42M Buy
50,088
+1,900
+4% +$161K 0.05% 405
2023
Q2 		$4.53M Buy
48,188
+3,700
+8% +$289K 0.06% 339
2023
Q1 		$3.02M Buy
44,488
+5,300
+14% +$341K 0.04% 402
2022
Q4 		$1.94M Sell
39,188
-4,700
-11% -$192K 0.03% 467
2022
Q3 		$1.73M Hold
43,888
– – 0.02% 514
2022
Q2 		$1.73M Sell
43,888
-13,300
-23% -$711K 0.02% 514
2022
Q1 		$4M Sell
57,188
-3,000
-5% -$219K 0.04% 441
2021
Q4 		$4.68M Buy
60,188
+3,488
+6% +$308K 0.04% 419
2021
Q3 		$5.41M Hold
56,700
– – 0.05% 375
2021
Q2 		$7.05M Sell
56,700
-2,200
-4% -$263K 0.06% 314
2021
Q1 		$7.76M Buy
58,900
+1,600
+3% +$219K 0.07% 275
2020
Q4 		$7.59M Buy
57,300
+3,500
+7% +$423K 0.07% 260
2020
Q3 		$5.49M Buy
53,800
+5,300
+11% +$458K 0.06% 308
2020
Q2 		$4.22M Sell
48,500
-3,300
-6% -$264K 0.05% 355
2020
Q1 		$3M Buy
51,800
+1,500
+3% +$122K 0.05% 380
2019
Q4 		$4.65M Buy
50,300
+13,400
+36% +$1.18M 0.06% 363
2019
Q3 		$3.33M Sell
36,900
-4,100
-10% -$467K 0.04% 431
2019
Q2 		$4.84M Buy
+41,000
New +$4.13M 0.06% 344

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Fjarde Ap-fonden's EXAS Position: Q2 2025 in Review

Fjarde Ap-fonden sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 38,488 shares — an estimated $1.67M sold.

Fjarde Ap-fonden first reported a position in EXAS in Q2 2019 and held it in 23 quarters. The position peaked at $7.76M in Q1 2021. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Fjarde Ap-fonden reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Fjarde Ap-fonden sold 38,488 Exact Sciences shares in Q2 2025, an estimated $1.67M.
  • Fjarde Ap-fonden first reported a position in Exact Sciences in Q2 2019 and held it in 23 quarters.
  • Fjarde Ap-fonden's Exact Sciences position peaked at $7.76M in Q1 2021.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Fjarde Ap-fonden's 13F filing for Q2 2025, filed 1 Aug 2025.